Learning from the 2009 H1N1 pandemic: Prospects for more broadly effective influenza vaccines

Journal of Molecular Cell Biology

Volumn 3, Issue 3, 2011, Pages 144-146

  Settembre, Ethan C ^a,b   Dormitzer, Philip R ^a,b   Rappuoli, Rino ^a,b  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL; ARTICLE; CLASSIFICATION; CROSS REACTION; GENETIC DRIFT; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MOLECULAR EVOLUTION; PANDEMIC;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; EVOLUTION, MOLECULAR; GENETIC DRIFT; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS;

EID: 79958210214     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjq046     Document Type: Article

References (11)

1. Centers for Disease Control (2010). Update: influenza activity-United States, 2009-10 season. MMWR Morb. Mortal. Wkly. Rep. 59, 901-908.
2. Clark, T.W., Pareek, M., Hoschler, K., et al. (2009). Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361, 2424-2435.
3. del Guidice, G., Sittelaar, K.J., van Amerongen, G., et al. (2009). Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci. Transl. Med. 1, 12re1.
4. Ekiert, D.C., Bhabha, G., Elsliger, M.A., et al. (2009). Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251.
5. Hancock, K., Veguilla, V., Lu, X., et al. (2009). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952.
6. Monto, A.S., and Kendal, A.P. (1973). Effect of neuraminidase antibody on Hong Kong influenza. Lancet 1, 623-625.
7. Okuno, Y., Isegawa, Y., Sasao, F., et al. (1993). A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552-2558. (Pubitemid 23118850)
8. Sui, J., Hwang, W.C., Perez, S., et al. (2009). Structural and functional bases for broadspectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273.
9. Wei, C.J., Boyington, J.C., McTamney, P.M., et al. (2010a). Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329, 1060-1064.
10. Wei, C.J., Boyington, J.C., Dai, K., et al. (2010b). Cross-neutralization of 1918 and 2009 in fluenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2, 24ra21.
11. Wrammert, J., Koutsonanos, D., Li, G.M., et al. (2011). Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181-193.